Latest Asx Compliance News

SPC Global Holdings (ASX: SPG) has voluntarily suspended trading of its shares pending details of a proposed equity raising, with the suspension expected to last until 11 May or until the announcement is made.

NT Minerals has launched a pro-rata non-renounceable entitlement offer aiming to raise up to $968,722 at $0.002 per share, providing shareholders a chance to subscribe for two shares for every five held. The offer opened on 5 May 2026 and closes on 26 May 2026, with electronic access to prospectus documents and a focus on reducing paper usage.

Klevo Rewards disclosed a $2 million incentive from Mastercard, triggering a trading halt and sparking consideration of an on-market share buy-back. The company addressed ASX concerns over disclosure timing and affirmed compliance with continuous disclosure rules.

Sunstone Metals has affirmed the materiality of its Bramaderos Gold-Copper Project scoping study following an ASX compliance letter addressing unusual share price movements prior to the study's release.

Botala Energy Ltd has denied holding undisclosed information following a sharp share price rise, linking the spike to a recent Serowe CBM Project announcement and confirming compliance with ASX disclosure rules.

Litchfield Minerals denies undisclosed material information behind recent share price jump, pointing to public engagement, media activity, and early-stage exploration sample processing as key influences.

Key Petroleum Ltd has wrapped up the last 3% tranche of its share placement, raising nearly $59,000 and exhausting its 15% ASX placement limit. The fresh capital is earmarked for asset acquisitions, development, and working capital.

Papyrus Australia (ASX: PPY) has secured $175,000 through a share placement alongside convertible note conversions and related party loans, aiming to fund commercialisation and fulfil a key contract for biodegradable Collar Keeper® products.

Gateway Mining attributes recent share price gains to a newly published independent research report, while confirming ongoing assay results from its Yandal Project remain under review and will be disclosed progressively starting 22 April 2026.

Atomo Diagnostics has responded to ASX queries confirming it first held market-sensitive information after Lumos Diagnostics’ FDA CLIA waiver approval for FebriDx. The company defended its trading halt and capital raise timing, asserting full compliance with ASX Listing Rules.

Emu NL's EMUOA securities have been suspended from trading by the ASX, pending compliance with listing rules. This move affects only the EMUOA class and signals regulatory scrutiny ahead of the company's next steps.

Proteomics International Laboratories has slashed a quarter of its workforce and appointed a new CFO amid a strategic pivot to commercial diagnostics, aiming to save over $1 million annually and sharpen execution.